| DB ID | MyCo_2337 |
| Title | Biomarkers for differentiation of coronavirus disease 2019 or extracorporeal membrane oxygenation related inflammation and bacterial/fungal infections in critically ill patients: A prospective observational study |
| Year | 2022 |
| PMID | 36275812 |
| Fungal Diseases involved | Fungal infection |
| Associated Medical Condition | COVID-19 |
| Genus | None |
| Species | None |
| Organism | None |
| Ethical Statement | The studies involving human participants were reviewed and approved by the Ethics Commitee of the Medical University of Vienna, Vienna, Austria (No. 1404/2020). |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | IL-10 |
| Biomarker Full Name | Interleukin-10 |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Austria |
| Cohort | This prospective observational study included patients with a positive real-time polymerase chain reaction for Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) from nasopharyngeal swabs and/or bronchial lavage, who had ongoing antimicrobial therapy for at least 48 h and were admitted to an ICU at the University Hospital Vienna. A total of 66 patients with a median age of 54 years and ongoing antimicrobial therapy were included in this study. |
| Cohort No. | 66 |
| Age Group | 54 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | ELISA Kit (R&D Systems, Minneapolis, USA), GM ELISA Kit (Platelia Aspergillus Kit, Bio-Rad Laboratories, CA, USA), |
| Assay Data | None |
| Validation Techniques used | ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
